Robert Stockton Jones Jr.

Array ( [id] => 505852 [patent_doc_number] => 07202280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'Methods for the treatment and prevention of pancreatitis and for induction of liver regeneration' [patent_app_type] => utility [patent_app_number] => 10/731626 [patent_app_country] => US [patent_app_date] => 2003-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18020 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202280.pdf [firstpage_image] =>[orig_patent_app_number] => 10731626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306547 [patent_doc_number] => 20040116533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/729764 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5135 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116533.pdf [firstpage_image] =>[orig_patent_app_number] => 10729764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990522 [patent_doc_number] => 20050089559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains' [patent_app_type] => utility [patent_app_number] => 10/727658 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3473 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089559.pdf [firstpage_image] =>[orig_patent_app_number] => 10727658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991510 [patent_doc_number] => 20050090547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains' [patent_app_type] => utility [patent_app_number] => 10/727655 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1992 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090547.pdf [firstpage_image] =>[orig_patent_app_number] => 10727655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906186 [patent_doc_number] => 20050101581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Therapeutic treatment methods 2' [patent_app_type] => utility [patent_app_number] => 10/728400 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 223643 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101581.pdf [firstpage_image] =>[orig_patent_app_number] => 10728400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325603 [patent_doc_number] => 20040138298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'NMDA receptor antagonist formulation with reduced neurotoxicity' [patent_app_type] => new [patent_app_number] => 10/729869 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14400 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138298.pdf [firstpage_image] =>[orig_patent_app_number] => 10729869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276348 [patent_doc_number] => 20040235799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Use of a compound with a negatively charged domain of radicals for the treatment of restenosis' [patent_app_type] => new [patent_app_number] => 10/478962 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5300 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235799.pdf [firstpage_image] =>[orig_patent_app_number] => 10478962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7240009 [patent_doc_number] => 20040157927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea' [patent_app_type] => new [patent_app_number] => 10/479205 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5977 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157927.pdf [firstpage_image] =>[orig_patent_app_number] => 10479205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7226012 [patent_doc_number] => 20040072902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Methods for inducing apoptosis and inhibiting proliferation in cancer cells' [patent_app_type] => new [patent_app_number] => 10/451555 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4144 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072902.pdf [firstpage_image] =>[orig_patent_app_number] => 10451555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169252 [patent_doc_number] => 20040077609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Oral composition containing NSAIDs and essential oils' [patent_app_type] => new [patent_app_number] => 10/719554 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4664 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077609.pdf [firstpage_image] =>[orig_patent_app_number] => 10719554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844687 [patent_doc_number] => 20060122261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => '[METHOD OF PREPARING LABDANE DITERPENE COMPOSITION, PREFERABLY ISOFORSKOLIN AND DEACETYLFORSKOLIN FROM FORSKOLIN EXTRACT AND THEIR USE FOR PROMOTING LEAN BODY MASS AND OTHER APPLICATIONS]' [patent_app_type] => utility [patent_app_number] => 10/707087 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3521 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122261.pdf [firstpage_image] =>[orig_patent_app_number] => 10707087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7475116 [patent_doc_number] => 20040097582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Use of a blood-flow decrease preventing agent in conjunction with insufflating gas' [patent_app_type] => new [patent_app_number] => 10/714980 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3294 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097582.pdf [firstpage_image] =>[orig_patent_app_number] => 10714980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7151423 [patent_doc_number] => 20040171697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy' [patent_app_type] => new [patent_app_number] => 10/712546 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6731 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171697.pdf [firstpage_image] =>[orig_patent_app_number] => 10712546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917335 [patent_doc_number] => 07323479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline' [patent_app_type] => utility [patent_app_number] => 10/704237 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23040 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323479.pdf [firstpage_image] =>[orig_patent_app_number] => 10704237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368345 [patent_doc_number] => 20040092571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/702930 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4626 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092571.pdf [firstpage_image] =>[orig_patent_app_number] => 10702930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325612 [patent_doc_number] => 20040138301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Chemical uncouplers for the treatment of obesity' [patent_app_type] => new [patent_app_number] => 10/699338 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34425 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138301.pdf [firstpage_image] =>[orig_patent_app_number] => 10699338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856830 [patent_doc_number] => 07375089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Rehydration composition' [patent_app_type] => utility [patent_app_number] => 10/697428 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5353 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375089.pdf [firstpage_image] =>[orig_patent_app_number] => 10697428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 919772 [patent_doc_number] => 07320976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-22 [patent_title] => 'Combination of brimonidine and timolol for topical ophthalmic use' [patent_app_type] => utility [patent_app_number] => 10/685941 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4026 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/320/07320976.pdf [firstpage_image] =>[orig_patent_app_number] => 10685941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199944 [patent_doc_number] => 20040086578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Physiologically acceptable aqueous solutions and methods for their use' [patent_app_type] => new [patent_app_number] => 10/684151 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12032 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086578.pdf [firstpage_image] =>[orig_patent_app_number] => 10684151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337461 [patent_doc_number] => 20040132798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => '3.7-Diazybicyclo [3.3.1] formulations as antiarrhythmic compounds' [patent_app_type] => new [patent_app_number] => 10/474591 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24224 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132798.pdf [firstpage_image] =>[orig_patent_app_number] => 10474591 [rel_patent_id] =>[rel_patent_doc_number] =>)